1. Home
  2. APYX vs PYPD Comparison

APYX vs PYPD Comparison

Compare APYX & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

N/A

Current Price

$2.92

Market Cap

107.4M

Sector

Health Care

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$6.53

Market Cap

107.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APYX
PYPD
Founded
1982
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.4M
107.0M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
APYX
PYPD
Price
$2.92
$6.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$6.50
★ $11.40
AVG Volume (30 Days)
142.0K
★ 154.8K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 19.40
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$12.42
N/A
Revenue Next Year
$11.05
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$3.50
52 Week High
$5.08
$7.15

Technical Indicators

Market Signals
Indicator
APYX
PYPD
Relative Strength Index (RSI) 61.87 71.78
Support Level $2.82 $4.26
Resistance Level $3.20 N/A
Average True Range (ATR) 0.20 0.41
MACD 0.06 0.11
Stochastic Oscillator 67.62 68.14

Price Performance

Historical Comparison
APYX
PYPD

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: